Please contact our law firm if you took Zofran while pregnant and your child has any of the following birth defects:
- Abdominal Birth Defects / Omphalocele
- Anal atresia (complete or partial closure of the anus)
- Cardiac (heart) defects
- Cleft palate or cleft lip
- Clubfoot (one or both feet turn downward and inward)
- Craniosynostosis (skull defect)
- Limb Defects
- Neural-tube defects (brain and spinal cord, spina bifida)
- PPHN (Persistent Pulmonary Hypertension of the Newborn)
Baum, Hedlund, Aristei & Goldman has extensive experience handling birth defect lawsuits and “off label” cases, where drug companies have promoted to doctors to prescribe their drugs for uses not approved by the FDA. Our firm has handled more than 1,300 birth defect cases related to five different pharmaceutical drugs over the past 10 years.
We have been representing victims of defective drugs since the late 1980s and we have recovered over $1.6 billion for our past clients in all areas of our practice, including birth defects lawsuits.**
Zofran® Morning Sickness
The Zofran birth defects lawsuit filed by two different women reveals the nature of the complaints being brought by those who took Zofran. In both cases the women were prescribed Zofran to alleviate morning sickness during their pregnancies.
A mother in Boston recently filed a Zofran birth defects lawsuit in the United States District Court of the District of Massachusetts. In her complaint, she states that she began taking Zofran early in the first trimester of her pregnancy. After birth, echocardiograms showed that her daughter (referred to as “A.S.” in the document) had a hole in the wall, or “septum,” that separates the two upper chambers of the heart, a condition known as atrial septal defect (ASD). The aorta, the main artery that supplies oxygenated blood to the body, was also deformed. A.S. was later diagnosed with facial deformities, hearing loss, and other defects. Over a 12 year period, she underwent 10 surgeries to try to correct her defects, which caused “substantial developmental delays,” according to the lawsuit.
In another case, a mother from Minnesota took Zofran to alleviate morning sickness during the first trimester of two pregnancies. Both her children were born with congenital heart defects and later suffered from developmental difficulties. Her Zofran birth defects lawsuit was filed in the U.S. District Court of the Eastern District of Pennsylvania.
In both cases, the mothers had no family history of birth defects and genetic testing did not detect genetic abnormalities.